Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization

Abstract

To study the changes in intratumoral microvessel density (MVD) in hepatocellular carcinoma (HCC) following transcatheter arterial chemoembolization (TACE), MVD in 42 HCC specimens histologically verified was studied by using immunohistochemical method. Of all the specimens, 20 were obtained from the patients treated with surgical resection alone, 22 from those with second stage surgical resection after TACE. The results showed that the MVD in HCC tissues was 53. 4±21. 9 in the TACE group and 27. 6±9. 2 in the single operating group, respectively, with the difference being significant between them (P<0. 001). It was suggested that TACE might contribute to angiogenesis of HCC, possibly due to anoxic stress and ischemia-reperfusion injury.

Keywords

hepatocellular carcinoma / chemoembolization / therapeutic / microvessel density

References

[1] ArayaM, TerashimaM, TakaganeA, et al. . Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol, 1997, 65232-232

[2] TanigawaN, LuC, MitsuiT, et al. . Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology, 1997, 261216-1216

[3] SunH C, TangZ Y, LiX M, et al. . Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol, 1999, 125419-419

[4] 1999,33(3):153

[5] KobayashiN, IshiiM, UenoY, et al. . Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver, 1999, 1925-25

[6] KimKM, BaeSK, LeeOH, et al. . Insulin-like growth factor I induced by hypoxia may contribute to angiogenesis of hepatocellular carcinoma. Cancer Res, 1998, 58348-348

[7] CollettiL M, RemickD G, BurtchGD, et al. . Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest, 1990, 851936-1936

[8] YamaguchiR, YanoH, IemuraA, et al. . Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology, 1998, 2868-68

[9] PrewettM, HuberJ, LiY, et al. . Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res, 1999, 595209-5209

[10] DrixlerT A, RinkesI H, RitchieED, et al. . Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastasis after partial hepatectomy. Cancer Res, 2000, 601761-1761